Notice: Images are for illustration only and may not reflect the exact product you receive. Brand-name medications may look different depending on their country of origin—Canadian versions, for example, often include a "PR" symbol on the packaging. Rest assured, the medication, dosage, and active ingredients will be exactly as prescribed. Canada Pharmacy Store is committed to your health and safety, and we work only with licensed pharmacies to ensure you receive trusted, high-quality medication every time.
General Medication Fact Sheet for Cathflo
| Field | Information |
|---|---|
| Medication Name | Cathflo |
| Generic Name | Alteplase |
| Boxed/Label Warning | Increased risk of bleeding, including intracranial hemorrhage. |
| Purpose | To restore function to central venous access devices (CVADs) blocked by blood clots. |
| Mechanism of Action | Alteplase is a tissue plasminogen activator (t-PA) that binds to fibrin in a thrombus and converts plasminogen to plasmin. Plasmin then breaks down the fibrin, dissolving the clot. |
| Dosage Forms | Lyophilized powder for solution |
| Available Strengths | 2 mg |
| Dosage Frequency | Instilled once, may be repeated if necessary. |
| Common Side Effects | Bleeding at the catheter site, infection, sepsis, thromboembolism. |
| Serious Side Effects | Intracranial hemorrhage, systemic bleeding, allergic reactions (anaphylaxis). |
| Drug Interactions | Anticoagulants (e.g., warfarin, heparin), antiplatelet agents (e.g., aspirin, clopidogrel), other thrombolytics. |
| Important Notes | Monitor patients closely for signs of bleeding. Use caution in patients with a history of bleeding disorders or recent surgery. |
| Storage | Store lyophilized powder at refrigerated temperature (2-8°C). Reconstituted solution should be used within 8 hours. |
| Missed Dose | This medication is administered by a healthcare professional. If a dose is missed, consult the healthcare provider for further instructions. |
| Alternatives | Urokinase, Streptokinase, Mechanical thrombectomy |
Cathflo Alternatives
| Medication | Mechanism of Action | Notes |
|---|---|---|
| Urokinase | Directly activates plasminogen to form plasmin, which degrades fibrin. | Another thrombolytic agent, less commonly used due to potential for allergic reactions and availability issues. |
| Streptokinase | Forms a complex with plasminogen, which then activates unbound plasminogen to form plasmin. | Another thrombolytic agent, more commonly associated with allergic reactions compared to alteplase. |
| Mechanical thrombectomy | Physical removal of the clot using specialized devices. | A non-pharmacological approach to clearing catheter occlusions. |
Cathflo Side Effects
| Common Side Effects | Serious Side Effects |
|---|---|
| Bleeding at the catheter site | Intracranial hemorrhage |
| Infection | Systemic bleeding |
| Sepsis | Allergic reactions (anaphylaxis) |
| Thromboembolism | Stroke |
| Fever | Pulmonary embolism |
Cathflo Dosage Guide
| Condition | Starting Dose | Maintenance Dose | Administration Notes |
|---|---|---|---|
| Central Venous Catheter Occlusion | 2 mg (1 mL) | N/A | Instill 2 mg (1 mL) into the occluded catheter. Wait 30 minutes, then attempt to aspirate blood. If catheter is still blocked after 30 minutes, a second dose may be administered, waiting another 30 minutes before attempting aspiration. Do not exceed two doses. |
Cathflo Price With And Without Insurance
| Purchase Context | Estimated Price |
|---|---|
| With Insurance | $50 |
| Without Insurance (U.S.) | $350 – $500 |
| From Canada | $90 |
